Seattle, WA, United States of America

Adalbert Jarzyna

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Avm Biotechnology, LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adalbert Jarzyna. Retrieved from https://idiyas.com/inventor/adalbert-jarzyna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Adalbert Jarzyna: Innovator in Pharmaceutical Formulations

Introduction

Adalbert Jarzyna is a notable inventor based in Seattle, WA. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of glucocorticoids. His innovative work has the potential to enhance the efficacy and safety of glucocorticoid treatments.

Latest Patents

Adalbert Jarzyna holds a patent for a stable glucocorticoid formulation. This invention relates to aqueous pharmaceutical formulations that comprise a glucocorticoid. These formulations are designed to contain high concentrations of glucocorticoid while minimizing the levels of preservatives. His patent is a testament to his commitment to improving pharmaceutical formulations.

Career Highlights

Jarzyna is currently associated with Avm Biotechnology, LLC, where he continues to work on innovative solutions in biotechnology. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry. With 1 patent to his name, he has demonstrated his ability to contribute to advancements in medical science.

Collaborations

Throughout his career, Adalbert has collaborated with notable professionals in the field, including Theresa A Deisher and Iain Duncan. These collaborations have allowed him to expand his knowledge and influence in the biotechnology sector.

Conclusion

Adalbert Jarzyna's work in developing stable glucocorticoid formulations showcases his innovative spirit and dedication to improving healthcare solutions. His contributions are paving the way for advancements in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…